Next Article in Journal
Acknowledgement to Reviewers of International Journal of Molecular Science in 2019
Next Article in Special Issue
Elucidating the H+ Coupled Zn2+ Transport Mechanism of ZIP4; Implications in Acrodermatitis Enteropathica
Previous Article in Journal
Mice Lacking the Matrilin Family of Extracellular Matrix Proteins Develop Mild Skeletal Abnormalities and Are Susceptible to Age-Associated Osteoarthritis
Previous Article in Special Issue
Report for the Sixth Meeting of the International Society for Zinc Biology (ISZB-2019)
Review

Advances of Zinc Signaling Studies in Prostate Cancer

1
Key Laboratory of Saline-alkali Vegetation Ecology Restoration, Ministry of Education, College of Life Science, Northeast Forestry University, Harbin 150040, China
2
College of Arts and Sciences, Winthrop University, Rock Hill, SC 29733, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(2), 667; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21020667
Received: 11 December 2019 / Revised: 16 January 2020 / Accepted: 17 January 2020 / Published: 19 January 2020
(This article belongs to the Special Issue Zinc Biology 2019)
Prostate cancer (PCa) is one of the most common cancers and the second leading cause of cancer-related death among men worldwide. Despite progresses in early diagnosis and therapeutic strategies, prognosis for patients with advanced PCa remains poor. Noteworthily, a unique feature of healthy prostate is its highest level of zinc content among all soft tissues in the human body, which dramatically decreases during prostate tumorigenesis. To date, several reviews have suggested antitumor activities of zinc and its potential as a therapeutic strategy of PCa. However, an overview about the role of zinc and its signaling in PCa is needed. Here, we review literature related to the content, biological function, compounds and clinical application of zinc in PCa. We first summarize zinc content in prostate tissue and sera of PCa patients with their clinical relevance. We then elaborate biological functions of zinc signaling in PCa on three main aspects, including cell proliferation, death and tumor metastasis. Finally, we discuss clinical applications of zinc-containing compounds and proteins involved in PCa signaling pathways. Based on currently available studies, we conclude that zinc plays a tumor suppressive role and can serve as a biomarker in PCa diagnosis and therapies. View Full-Text
Keywords: zinc; prostate cancer; signaling pathway; proliferation; apoptosis; metastasis; zinc transporter; zinc finger; cancer therapy zinc; prostate cancer; signaling pathway; proliferation; apoptosis; metastasis; zinc transporter; zinc finger; cancer therapy
Show Figures

Figure 1

MDPI and ACS Style

Li, D.; Stovall, D.B.; Wang, W.; Sui, G. Advances of Zinc Signaling Studies in Prostate Cancer. Int. J. Mol. Sci. 2020, 21, 667. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21020667

AMA Style

Li D, Stovall DB, Wang W, Sui G. Advances of Zinc Signaling Studies in Prostate Cancer. International Journal of Molecular Sciences. 2020; 21(2):667. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21020667

Chicago/Turabian Style

Li, Dangdang, Daniel B. Stovall, Wenmeng Wang, and Guangchao Sui. 2020. "Advances of Zinc Signaling Studies in Prostate Cancer" International Journal of Molecular Sciences 21, no. 2: 667. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21020667

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop